Talha Burki

9.3k total citations · 3 hit papers
630 papers, 5.9k citations indexed

About

Talha Burki is a scholar working on Infectious Diseases, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Talha Burki has authored 630 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Infectious Diseases, 78 papers in General Health Professions and 72 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Talha Burki's work include Global Public Health Policies and Epidemiology (39 papers), Health and Conflict Studies (24 papers) and Vaccine Coverage and Hesitancy (23 papers). Talha Burki is often cited by papers focused on Global Public Health Policies and Epidemiology (39 papers), Health and Conflict Studies (24 papers) and Vaccine Coverage and Hesitancy (23 papers). Talha Burki collaborates with scholars based in United Kingdom, Switzerland and United States. Talha Burki's co-authors include Judit Lienert, Beate I. Escher and Douglas S. Clark and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Lancet Neurology.

In The Last Decade

Talha Burki

569 papers receiving 5.7k citations

Hit Papers

The online anti-vaccine movement in the age of COVID-19 2020 2026 2022 2024 2020 2021 2022 50 100 150 200

Peers

Talha Burki
Rosemary Morgan United States
Elisabeth Mahase United Kingdom
Jue Liu China
Siddappa N. Byrareddy United States
Rosemary Morgan United States
Talha Burki
Citations per year, relative to Talha Burki Talha Burki (= 1×) peers Rosemary Morgan

Countries citing papers authored by Talha Burki

Since Specialization
Citations

This map shows the geographic impact of Talha Burki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Talha Burki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Talha Burki more than expected).

Fields of papers citing papers by Talha Burki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Talha Burki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Talha Burki. The network helps show where Talha Burki may publish in the future.

Co-authorship network of co-authors of Talha Burki

This figure shows the co-authorship network connecting the top 25 collaborators of Talha Burki. A scholar is included among the top collaborators of Talha Burki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Talha Burki. Talha Burki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burki, Talha. (2025). Call to prioritise access to essential cancer medicines in Latin America and the Caribbean. The Lancet Oncology. 26(3). 286–286. 1 indexed citations
2.
Burki, Talha. (2025). UK Government dismantles the Fleming Fund. The Lancet Microbe. 6(11). 101239–101239.
3.
Burki, Talha. (2025). WHO, USAID, PEPFAR: first targets of Trump's presidency. The Lancet Microbe. 6(3). 101101–101101. 3 indexed citations
4.
Burki, Talha. (2024). Avian influenza in cattle in the USA. The Lancet Infectious Diseases. 24(7). e424–e425. 2 indexed citations
5.
Burki, Talha. (2024). Poor progress on reducing alcohol consumption in Europe. The Lancet Oncology. 25(9). 1120–1120. 1 indexed citations
6.
Burki, Talha. (2024). WHO's 2024 global hepatitis report. The Lancet Infectious Diseases. 24(6). e362–e363. 19 indexed citations
7.
Burki, Talha. (2024). Tobacco and e-cigarette use in young people: an ongoing challenge. The Lancet Oncology. 25(7). 835–835. 1 indexed citations
8.
Burki, Talha. (2024). West Nile virus in the USA. The Lancet. 404(10448). 108–109. 2 indexed citations
9.
Burki, Talha. (2023). The future of childhood immunisation. The Lancet Respiratory Medicine. 11(7). e72–e72. 1 indexed citations
10.
Burki, Talha. (2023). WHO ends the COVID-19 public health emergency. The Lancet Respiratory Medicine. 11(7). 588–588. 36 indexed citations
11.
Burki, Talha. (2023). Nipah virus: an ever-present threat. The Lancet Infectious Diseases. 23(11). e473–e474. 1 indexed citations
12.
Burki, Talha. (2021). FDA approval for anifrolumab in patients with lupus. The Lancet Rheumatology. 3(10). e689–e689. 15 indexed citations
13.
Burki, Talha. (2021). COVID-19 among American Indians and Alaska Natives. The Lancet Infectious Diseases. 21(3). 325–326. 29 indexed citations
14.
Burki, Talha. (2018). Responses to carboplatin in BRCA1/2-mutated breast cancer. The Lancet Oncology. 19(7). e337–e337. 3 indexed citations
15.
Burki, Talha. (2018). Increase in detentions in the UK under the Mental Health Act. The Lancet Psychiatry. 5(11). 878–878. 3 indexed citations
16.
Burki, Talha. (2017). Defining precision medicine. The Lancet Oncology. 18(12). e719–e719. 3 indexed citations
17.
Burki, Talha. (2017). Improved progression-free survival in metastatic breast cancer. The Lancet Oncology. 19(2). e79–e79. 1 indexed citations
18.
Burki, Talha. (2016). Counting the cost of end-of-life cancer care. The Lancet Oncology. 17(3). e91–e91. 4 indexed citations
19.
Burki, Talha. (2015). Adjuvant treatment for HER2-positive breast cancer. The Lancet Oncology. 16(2). e59–e59. 16 indexed citations
20.
Burki, Talha. (2014). Flexible sigmoidoscopy screening for colorectal cancer. The Lancet Oncology. 15(10). e425–e425. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026